Artificial Womb Supports Premature Fetal Lamb Development

The lungs of extremely premature lambs supported in a closed, sterile environment that enables fluid-based gas exchange grow and develop normally, researchers report.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

YOUTUBE, CHILDREN'S HOSPITAL OF PHILADELPHIAFetal lambs that are developmentally similar to human infants born extremely prematurely (as early as at 23 weeks of gestation) can survive and continue to develop in an artificial womb for up to four weeks, researchers at the Children’s Hospital of Philadelphia Research Institute reported in Nature Communications today (April 25). In its paper, the team described its womb-like system, which notably differs from previous artificial womb setups in that it enables gas exchange to the fetus in a closed, sterile, fluid environment.

“We’ve developed a system that—as closely as possible—reproduces the environment of the womb and replaces the function of the placenta,” coauthor Alan Flake told reporters during an April 24 press briefing. “This, in theory, could allow support of a premature infant for a period of weeks and thereby reduce, dramatically, its mortality and morbidity, and improve outcomes both short- and long-term.”

Eight lambs survived as long as four weeks inside the devices, which connected the animals’ umbilical cords to machinery enabling fluid gas exchange to their developing lungs. “Infants that are currently born and supported in a neonatal intensive care unit with gas-based ventilation demonstrate an arrest of lung development, which manifests in the long term with severe restriction of function, which can translate into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies